From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.73
First Reported 2006
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 5
Total Number 5
Disease Relevance 3.91
Pain Relevance 0.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (GPT) small molecule metabolic process (GPT) biosynthetic process (GPT)
cellular nitrogen compound metabolic process (GPT) cytoplasm (GPT)
Anatomy Link Frequency
lymph node 1
auditory tube 1
kidney 1
body 1
GPT (Homo sapiens)
Pain Link Frequency Relevance Heat
Chronic pancreatitis 1 96.28 Very High Very High Very High
alcohol 2 93.12 High High
addiction 1 92.48 High High
imagery 3 79.52 Quite High
withdrawal 1 72.20 Quite High
depression 5 45.28 Quite Low
Pain 7 5.00 Very Low Very Low Very Low
antagonist 4 5.00 Very Low Very Low Very Low
Calcium channel 3 5.00 Very Low Very Low Very Low
headache 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 4 100.00 Very High Very High Very High
Disorder Of Lipid Metabolism 7 98.68 Very High Very High Very High
Cancer 37 98.56 Very High Very High Very High
Hepatotoxicity 8 98.50 Very High Very High Very High
Malignant Neoplastic Disease 4 97.98 Very High Very High Very High
Gallstones 1 96.60 Very High Very High Very High
Pancreatitis 1 96.28 Very High Very High Very High
Otitis Media With Effusion 1 94.74 High High
Metastasis 4 94.46 High High
Drug Hypersensitivity 1 94.32 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Additional variables of interest: body weight, body mass index BMI, body fat percentage, fat mass, fat-free mass, water mass (analysis of body composition by tetrapolar bioimpedance analysis), assessment of an arteriosclerotic risk profile by blood investigation of variables of lipid metabolism (cholesterol, triglycerides, high density lipoproteins HDL, low density lipoproteins LDL, apolipoprotein A1, apolipoprotein B), clinical chemistry (fasting glucose, alanin-aminotransferase ALT (= glutamyl pyruvic transaminase GPT), gamma-glutamyl-transferase GGT, creatinine, albumin), endocrinology (leptin, adiponectin (= adipo Q), homocysteine, insulin).
Localization (creatinine) of ALT in body associated with body weight, obesity and disorder of lipid metabolism
1) Confidence 0.73 Published 2006 Journal GMS German Medical Science Section Abstract Doc Link PMC2703221 Disease Relevance 0.55 Pain Relevance 0
Patient demographics (age at diagnosis, race, gender), tumor characteristics (localization, size, presence of lymph node metastasis, differentiation), personal medical history (history of other cancer, chronic pancreatitis, cholelithiasis, early onset diabetes mellitus) and history of cancer in first degree relatives, laboratory tests at diagnosis (aspartate aminotransferase-AST, alanine aminotransferase-ALT, alkaline phosphatase-ALP, albumin, total bilirubin) and tumor markers preoperatively (CA 19-9, carcinoembryonic antigen-CEA), surgical resection (totaland distal-pancreatectomy and splenectomy, Whipple resection) are shown in Table 1.
Localization (alkaline phosphatase) of ALT in lymph node associated with diabetes mellitus, cancer, gallstones, chronic pancreatitis and metastasis
2) Confidence 0.73 Published 2010 Journal Cancer Informatics Section Body Doc Link PMC2865167 Disease Relevance 1.32 Pain Relevance 0.10
stimulating hormone (TSH), alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotranferase (ALT) and urinary excretion of sodium in 24 h.

Localization (excretion) of ALT
3) Confidence 0.73 Published 2010 Journal Clinics (Sao Paulo) Section Body Doc Link PMC2974815 Disease Relevance 0.53 Pain Relevance 0.06
We excluded patients with active chronic otitis media, acute otitis media, otitis media with effusion or dysfunction of the auditory tube, a history of previous treatments (except for systemic application of glucocorticoids or prostaglandin E1), malignant tumours, severe liver dysfunction (aspartate aminotransferase (AST) >100 IU/L and alanine aminotransferase (ALT) >100 IU/L), uncontrolled diabetes (haemoglobin A1C (HbA1c) >10%), pituitary or adrenal dysfunction, severe systemic illness that affected life expectancy, a history of severe drug allergy, or a history of alcohol or drug dependence within the past 1 year, and pregnant or lactating women.
Localization (diabetes) of ALT in auditory tube associated with drug dependence, otitis media, diabetes mellitus, alcohol, addiction, malignant neoplastic disease, hepatotoxicity, otitis media with effusion and drug hypersensitivity
4) Confidence 0.73 Published 2010 Journal BMC Med Section Body Doc Link PMC3000370 Disease Relevance 1.09 Pain Relevance 0.13
2.0 mg/dL, aspartate aminotransferase (AST)/alanine aminotransferase (ALT) < 3 × upper limit of normal), and kidney (serum creatinine (Crt) ?
Localization (aspartate aminotransferase) of alanine aminotransferase in kidney
5) Confidence 0.73 Published 2010 Journal BMC Complement Altern Med Section Body Doc Link PMC3014873 Disease Relevance 0.42 Pain Relevance 0

General Comments

This test has worked.

Personal tools